Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
European Urology
|
January 1, 1993
Overview of current status of total androgen deprivation in metastasized prostate cancer
F M Debruyne, W P Witjes
Molecular Urology
|
November 4, 2000
Neoadjuvant hormonal therapy prior to radical prostatectomy: the European experience
F M Debruyne, W P Witjes
World Journal of Urology
|
January 1, 1993
Overview of the current status of total androgen deprivation in metastasized prostate cancer
F M Debruyne, W P Witjes
Nederlands Tijdschrift Voor Tandheelkunde
|
April 1, 1992
[Prostate cancer]
P Fernandez del Moral, W P Witjes
Urology
|
March 1, 1997
Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Treatment of Prostate Cancer
W P Witjes, C C Schulman, F M Debruyne
The Prostate
|
December 1, 1995
Current status of neoadjuvant therapy in localized prostate cancer
W P Witjes, G O Oosterhof, H E Schaafsma, et al.
British Journal of Urology
|
November 14, 1997
Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group
J M Buzelin, E Fonteyne, M Kontturi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 1, 1995
The value of neoadjuvant therapy in localized prostate cancer
W P Witjes, G O Oosterhof, H E Schaafsma, et al.
Seminars in Urologic Oncology
|
February 1, 1996
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group
W P Witjes, J A Witjes, G O Oosterhof, et al.
Urology
|
August 1, 1997
Quantitative assessment of uroflow: is there a circadian rhythm?
W P Witjes, H Wijkstra, F M Debruyne, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
European Urology
|
January 1, 1993
Overview of current status of total androgen deprivation in metastasized prostate cancer
F M Debruyne, W P Witjes
Molecular Urology
|
November 4, 2000
Neoadjuvant hormonal therapy prior to radical prostatectomy: the European experience
F M Debruyne, W P Witjes
World Journal of Urology
|
January 1, 1993
Overview of the current status of total androgen deprivation in metastasized prostate cancer
F M Debruyne, W P Witjes
Nederlands Tijdschrift Voor Tandheelkunde
|
April 1, 1992
[Prostate cancer]
P Fernandez del Moral, W P Witjes
Urology
|
March 1, 1997
Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Treatment of Prostate Cancer
W P Witjes, C C Schulman, F M Debruyne
The Prostate
|
December 1, 1995
Current status of neoadjuvant therapy in localized prostate cancer
W P Witjes, G O Oosterhof, H E Schaafsma, et al.
British Journal of Urology
|
November 14, 1997
Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group
J M Buzelin, E Fonteyne, M Kontturi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 1, 1995
The value of neoadjuvant therapy in localized prostate cancer
W P Witjes, G O Oosterhof, H E Schaafsma, et al.
Seminars in Urologic Oncology
|
February 1, 1996
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group
W P Witjes, J A Witjes, G O Oosterhof, et al.
Urology
|
August 1, 1997
Quantitative assessment of uroflow: is there a circadian rhythm?
W P Witjes, H Wijkstra, F M Debruyne, et al.
Page
of 5